These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32741939)

  • 1. Enhanced Immunostimulatory Activity of CpG Oligodeoxynucleotide by the Combination of Mannose Modification and Incorporation into Nanostructured DNA.
    Liao W; Akahira S; Hara RI; Wada T; Kusamori K; Takakura Y; Nishikawa M
    Biol Pharm Bull; 2020; 43(8):1188-1195. PubMed ID: 32741939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Delivery of Immunostimulatory CpG Oligodeoxynucleotides to Antigen-Presenting Cells in Draining Lymph Nodes by Stearic Acid Modification and Nanostructurization.
    Nagaoka M; Liao W; Kusamori K; Nishikawa M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning CpG motif position in nanostructured DNA for efficient immune stimulation.
    Tan M; Makiguchi N; Kusamori K; Itakura S; Takahashi Y; Takakura Y; Nishikawa M
    Biotechnol J; 2024 Apr; 19(4):e2300308. PubMed ID: 38651249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of chemically modified nucleobases and nanostructured DNA for enhanced immunostimulatory activity of CpG oligodeoxynucleotide.
    Araie Y; Ohtsuki S; Park S; Nagaoka M; Umemura K; Sugiyama H; Kusamori K; Takahashi Y; Takakura Y; Nishikawa M
    Bioorg Med Chem; 2021 Jan; 29():115864. PubMed ID: 33223462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Stimulation of Toll-Like Receptor 9 by CpG Oligodeoxynucleotides Incorporated Into Polypod-Like DNA Nanostructures.
    Takahashi Y; Maezawa T; Araie Y; Takahashi Y; Takakura Y; Nishikawa M
    J Pharm Sci; 2017 Sep; 106(9):2457-2462. PubMed ID: 28385547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Monomeric and Dimeric G-Quadruplex-Structured CpG Oligodeoxynucleotides for Enhanced Uptake and Activation in TLR9-Positive Macrophages.
    Liao W; Tan M; Kusamori K; Takakura Y; Nishikawa M
    Nucleic Acid Ther; 2020 Oct; 30(5):299-311. PubMed ID: 32559406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells.
    Mohri K; Nishikawa M; Takahashi N; Shiomi T; Matsuoka N; Ogawa K; Endo M; Hidaka K; Sugiyama H; Takahashi Y; Takakura Y
    ACS Nano; 2012 Jul; 6(7):5931-40. PubMed ID: 22721419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Activity of Immunosuppressive Oligodeoxynucleotides by Incorporating Them into Hexapod-Like Nanostructured DNA.
    Araie Y; Takahashi Y; Takahashi Y; Takakura Y; Nishikawa M
    Biol Pharm Bull; 2018; 41(4):564-569. PubMed ID: 29607929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure.
    Mohri K; Nagata K; Ohtsuki S; Toyama S; Nonomura M; Takahashi Y; Takakura Y; Nishikawa M; Sakuma S
    Pharm Res; 2017 Nov; 34(11):2362-2370. PubMed ID: 28791533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery.
    Nishikawa M; Ogawa K; Umeki Y; Mohri K; Kawasaki Y; Watanabe H; Takahashi N; Kusuki E; Takahashi R; Takahashi Y; Takakura Y
    J Control Release; 2014 Apr; 180():25-32. PubMed ID: 24530618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of immunostimulatory DNA to mouse and human immune cells through the construction of polypod-like structured DNA.
    Uno S; Nishikawa M; Mohri K; Umeki Y; Matsuzaki N; Takahashi Y; Fujita H; Kadowaki N; Takakura Y
    Nanomedicine; 2014 May; 10(4):765-74. PubMed ID: 24333587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S; Nishikawa M; Takakura Y
    Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypod-Shaped DNAs: Small-Angle X-ray Scattering and Immunostimulatory Activity.
    Sanada Y; Shiomi T; Okobira T; Tan M; Nishikawa M; Akiba I; Takakura Y; Sakurai K
    Langmuir; 2016 Apr; 32(15):3760-5. PubMed ID: 27007061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides.
    Jin L; Raymond DP; Crabtree TD; Pelletier SJ; Houlgrave CW; Pruett TL; Sawyer RG
    J Immunol; 2000 Nov; 165(9):5153-60. PubMed ID: 11046047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-quadruplex-based CpG oligodeoxynucleotide/DOTAP complex strongly stimulates immunity in CpG motif-specific and loop-length-dependent manners.
    Tu ATT; Hoshi K; Shobo M; Yamazaki T
    Nanomedicine; 2022 Feb; 40():102508. PubMed ID: 34906721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.